InvestSMART

4DMedical Limited (ASX: 4DX) - Announcements

Current share price for 4DX : $3.520 0.08 (2.22%)+

ASX company news and announcements for 4DMedical Limited (4DX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All 4DMedical Limited (4DX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than 4DMedical Limited (4DX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for 4DMedical Limited (4DX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$2,112 4DMedical receives U.S. FDA clearance for IQ-UIP 7 Jan 2025 2:12PM $0.455 $3.520 risen by 673.63%
$2,112 Cleansing Notice 20 Dec 2024 10:01AM $0.445 $3.520 risen by 691.01%
$2,112 Application for quotation of securities - 4DX 20 Dec 2024 9:55AM $0.455 $3.520 risen by 673.63%
$2,112 Director change to non-executive role 20 Dec 2024 9:52AM $0.455 $3.520 risen by 673.63%
$2,112 4DMedical wins contract with University of Chicago Medicine 16 Dec 2024 8:34AM $0.465 $3.520 risen by 656.99%
$2,112 4DMedical unveils CT VQ at RSNA 2024 4 Dec 2024 9:17AM $0.480 $3.520 risen by 633.33%
$2,112 4DMedical signs contract to expand in Western Australia 2 Dec 2024 9:49AM $0.460 $3.520 risen by 665.22%
$2,112 Application for quotation of securities - 4DX 29 Nov 2024 1:28PM $0.445 $3.520 risen by 691.01%
$2,112 4DMedical wins commercial contract with IPOC 25 Nov 2024 10:30AM $0.445 $3.520 risen by 691.01%
$2,112 Change of Director's Interest Notice 22 Nov 2024 2:23PM $0.463 $3.520 risen by 661.08%
$2,112 Change of Director's Interest Notice 22 Nov 2024 2:23PM $0.463 $3.520 risen by 661.08%
$2,112 Change of Director's Interest Notice 22 Nov 2024 2:21PM $0.463 $3.520 risen by 661.08%
$2,112 Change of Director's Interest Notice 22 Nov 2024 2:20PM $0.463 $3.520 risen by 661.08%
$2,112 Change of Director's Interest Notice 22 Nov 2024 2:17PM $0.463 $3.520 risen by 661.08%
$2,112 Change of Director's Interest Notice 22 Nov 2024 2:17PM $0.463 $3.520 risen by 661.08%
$2,112 Notification regarding unquoted securities - 4DX 22 Nov 2024 2:06PM $0.463 $3.520 risen by 661.08%
$2,112 Results of AGM 20 Nov 2024 2:39PM $0.485 $3.520 risen by 625.77%
$2,112 AGM Presentation and Chair's address 20 Nov 2024 8:27AM $0.510 $3.520 risen by 590.20%
$2,112 4DMedical wins 3 year commercial contract with UCSD Health 19 Nov 2024 9:15AM $0.480 $3.520 risen by 633.33%
$2,112 Application for quotation of securities - 4DX 15 Nov 2024 1:46PM $0.470 $3.520 risen by 648.94%
$2,112 Application for quotation of securities - 4DX 8 Nov 2024 1:48PM $0.515 $3.520 risen by 583.50%
$2,112 Notification regarding unquoted securities - 4DX 1 Nov 2024 2:07PM $0.520 $3.520 risen by 576.92%
$2,112 Quarterly Activity Report and Appendix 4C for Q1 FY2025 31 Oct 2024 9:06AM $0.510 $3.520 risen by 590.20%
$2,112 4DMedical wins $1.9m funding for CT VQ clinical studies 23 Oct 2024 8:25AM $0.515 $3.520 risen by 583.50%
$2,112 Notice of Annual General Meeting / Proxy Form 18 Oct 2024 10:00AM $0.565 $3.520 risen by 523.01%

251 - 275 of 596 results

Page 11 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.